Gudcef Dry Syrup contains Cefpodoxime Proxetil 50 mg, a third-generation cephalosporin antibiotic effective against a broad spectrum of bacterial infections. It is indicated for the treatment of respiratory tract infections such as bronchitis, pneumonia, and sinusitis, as well as urinary tract infections, skin and soft tissue infections, and uncomplicated gonorrhea. Cefpodoxime Proxetil works by inhibiting bacterial cell wall synthesis, thereby exerting a bactericidal effect. Gudcef Dry Syrup is formulated for pediatric use, providing an easy-to-administer oral suspension upon reconstitution. The medication demonstrates good oral bioavailability and is well tolerated in children. Dosage should be based on the severity of the infection and the patient’s weight, typically administered twice daily. Common adverse effects may include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort. Hypersensitivity reactions, although rare, can occur and warrant immediate medical attention. It is contraindicated in patients with a known allergy to cephalosporins or penicillins. Caution is advised in patients with renal impairment, and dosage adjustments may be necessary. Gudcef Dry Syrup should be used under medical supervision, ensuring adherence to the prescribed course to prevent resistance development and achieve optimal therapeutic outcomes.